GH Research PLC

NASDAQ (USD): GH Research PLC (GHRS)

Last Price

19.26

Today's Change

+8.66 (81.69%)

Day's Change

18.30 - 20.50

Trading Volume

7,740,288

Overview

Market Cap

991 Million

Shares Outstanding

52 Million

Avg Volume

78,735

Avg Price (50 Days)

8.56

Avg Price (200 Days)

9.92

PE Ratio

-24.13

EPS

-0.79

Earnings Announcement

27-Feb-2025

Previous Close

10.60

Open

20.00

Day's Range

18.3 - 20.5

Year Range

6.0 - 20.5

Trading Volume

7,776,466

Price Change Highlight

1 Day Change

79.81%

5 Day Change

101.48%

1 Month Change

111.07%

3 Month Change

133.87%

6 Month Change

59.90%

Ytd Change

140.96%

1 Year Change

151.45%

3 Year Change

10.17%

5 Year Change

-0.99%

10 Year Change

-0.99%

Max Change

-0.99%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that has completed two Phase 1 clinical trials and Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an injectable 5-MeO-DMT product candidate; and GH003, an intranasal 5-MeO-DMT product candidate, which are in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment